Latham Advises Platinum Equity on Acquisition of Inventia Healthcare

Latham & Watkins has advised Platinum Equity, a global private equity investment firm, on the acquisition of Inventia Healthcare, a pharmaceutical development and manufacturing company of solid oral drug delivery systems.

The Latham team was led by Singapore corporate partner Sidharth Bhasin and counsel Michael Rackham, with associates Mark Hu, Elisabeth Su-Li Ong, Cherine Teh, Benjamin Han, and Zoe Wang. Advice was provided on healthcare matters by Washington, D.C. partner Christopher Schott and Paris partner Eveline Van Keymeulen, with associates Oliver Mobasser, Jeanne Fabre, and Elisabeth Crusey.